What Are the Gulf War Presumptive Illnesses?

Gulf War presumptive illnesses are health conditions that the U.S. Department of Veterans Affairs (VA) presumes were caused by military service during the 1990–1991 Gulf War, meaning affected veterans do not have to prove a direct link between their service and their diagnosis to receive benefits. The list has expanded over the decades and now spans chronic multi-symptom illness (commonly called Gulf War Illness), specific infectious diseases, respiratory conditions tied to burn pit and other toxic exposures, and certain cancers. The concept of “presumptive” is a legal and policy tool rather than a strict medical one, and understanding what it covers, what it misses, and why these conditions developed in the first place requires looking at both the science and the legislation that have shaped how these veterans are treated.

How “Presumptive” Status Works

When the VA grants presumptive status to a condition, it means any veteran who served in a qualifying location during a qualifying period and later develops that condition is assumed to have gotten it from their service. The veteran does not need to dig up deployment records showing they stood downwind of a particular burn pit or swallowed a particular pill. This matters enormously because many Gulf War exposures were poorly documented at the time, and proving individual causation decades later is often impossible. The presumptive framework shifts the burden of proof away from the veteran.

The most significant recent expansion came through the PACT Act, signed into law in 2022. That legislation dramatically broadened the list of presumptive conditions for veterans exposed to burn pits, airborne hazards, and other toxic substances. Before the PACT Act, many veterans with conditions strongly suspected to be service-related spent years in appeals trying to establish a connection. The act treated the problem as one of legal policy rather than waiting for ironclad scientific proof of each individual exposure-disease link.

The Conditions on the List

Gulf War presumptive conditions fall into several broad categories. The first and most widely discussed is chronic multi-symptom illness, or Gulf War Illness (GWI), a cluster of symptoms including fatigue, widespread pain, cognitive problems, gastrointestinal disturbances, and skin abnormalities that have persisted for years. Depending on which case definition researchers use, GWI affects somewhere between roughly 14% and 42% of deployed veterans, a wide range that reflects disagreements over how strict the diagnostic criteria should be.¹ The narrower “Research” definition captures veterans with more numerous and severe symptoms, while broader definitions like the CDC and Modified Kansas criteria capture a much larger group that includes milder cases.

Beyond GWI as a syndrome, the VA recognizes specific diseases as presumptive for Gulf War veterans. These include:

Respiratory conditions: Asthma diagnosed after service, chronic bronchitis, COPD, chronic sinusitis and rhinitis, constrictive bronchiolitis, emphysema, interstitial lung disease, pulmonary fibrosis, sarcoidosis, and granulomatous disease.
Cancers: Several cancers including those of the head, neck, respiratory tract, gastrointestinal tract, reproductive system, kidney, urinary system, and others now fall under the PACT Act’s expanded presumptive list.
Infectious diseases: Certain infections endemic to the Gulf region, including viscerotropic leishmaniasis, are recognized, though confirmed chronic cases of that particular infection were extremely rare, identified in only about 12 U.S. veterans.²
Functional gastrointestinal disorders: Irritable bowel syndrome and functional dyspepsia.
Other chronic conditions: Fibromyalgia, chronic fatigue syndrome, and undiagnosed illnesses manifesting with qualifying symptoms.

The PACT Act specifically added many of the respiratory conditions and cancers, treating them as presumptively connected to burn pit and other toxic exposures rather than requiring veterans to individually prove the link.³

Why Gastrointestinal Problems Are So Common

Gut issues are among the most persistent and widespread complaints in Gulf War veterans, and the numbers are striking. Before deployment, about 16% of veterans reported functional gastrointestinal disorders. During deployment, that jumped to roughly 50%, and by 16 years after deployment it had climbed to about 64%.⁴ That is not a temporary spike that resolves when soldiers come home. In a study of deployed veterans, about one in five developed irritable bowel syndrome during deployment, and nearly half developed diarrhea, with these symptoms commonly persisting long after returning home.⁵

The most frequently reported gastrointestinal disorders among Gulf War veterans with GWI are IBS, gastroesophageal reflux disease, and colon polyps. Veterans who also have PTSD fare worse: their odds of having IBS are roughly three times higher than veterans with GWI alone, and their odds of reflux disease are about twice as high.⁶ Gastroenteritis during deployment itself turned out to be a strong predictor of later IBS, dyspepsia, and chronic diarrhea, suggesting that acute infections in the field set up long-term gut dysfunction.

Animal research has started to explain why these gut problems last so long. In a mouse model using pyridostigmine bromide (a chemical Gulf War veterans were given as a nerve agent pretreatment), researchers found structural changes in the gut’s nervous system, an imbalance in the neurons controlling gut movement, and a sustained influx of inflammatory immune cells. The result was persistent, low-grade inflammation in the gut wall that chronically impaired normal digestive movement.⁷

The Chemical Cocktail Behind Gulf War Illness

During the Gulf War, service members were exposed to a remarkable mix of chemicals, often simultaneously. Three in particular have drawn the most research attention: pyridostigmine bromide (PB), the insect repellent DEET, and the insecticide permethrin. PB was given to troops as a pretreatment pill in case of nerve agent attack. DEET and permethrin were used to protect against sand flies and other insects in the desert.

Individually, each chemical caused minimal harm at the doses used. But when combined, the picture changed dramatically. Animal studies found that exposing subjects to two of these agents produced more neurological damage than any single agent, and all three together caused even greater harm.⁸ The proposed explanation is that PB blocks certain enzymes in the liver and blood that would normally break down DEET and permethrin, essentially allowing more of those chemicals to reach the brain intact. Follow-up studies confirmed that combined exposure to PB, DEET, and permethrin produced measurable deficits in coordination, grip strength, and balance in animals, along with disruption of the brain’s cholinergic system.⁹

Survey data from veterans themselves supports the laboratory findings. In a survey of over 700 male Reserve Component veterans, having taken pyridostigmine bromide pills was a significant predictor of worsened self-reported health after the war, even after accounting for other possible factors.¹⁰

Genetics may also play a role in determining who got sick. A study examining the interaction between a specific gene variant (PON1, which affects how well the body detoxifies certain chemicals) and possible low-level nerve agent exposure found that veterans with a particular genetic profile who also reported hearing nerve agent alarms during service had more than three times the odds of developing GWI compared to what either factor alone would predict.¹¹ This suggests that individual biology influenced who was most vulnerable to the theater’s chemical environment.

Other Exposures and What the Evidence Shows

The Gulf War involved several other environmental hazards beyond the chemical cocktail discussed above. Two of the most prominent were Kuwaiti oil well fire smoke and depleted uranium munitions. The evidence on each has evolved differently.

For oil well fire smoke, the epidemiological data has been largely reassuring. A study using Department of Defense hospitalization records found no consistent increase in postwar hospitalization risk from oil well fire exposure and no dose-response relationship, meaning heavier exposure did not lead to more health problems.¹² That does not rule out all effects, but it suggests oil well smoke was not a primary driver of the chronic illness burden.

Depleted uranium is a different story, though a nuanced one. A cohort of veterans who were in or on vehicles hit by friendly fire involving DU munitions has been monitored since the early 1990s. Those with retained DU shrapnel fragments continue to excrete elevated uranium in their urine decades later, confirming ongoing internal exposure.¹³ Despite this, kidney function has remained clinically normal, which was unexpected given that the kidney is the organ most vulnerable to uranium toxicity. However, subtle changes in kidney markers and some mixed signals on genetic damage have kept researchers watchful.¹⁴

After 30 years of follow-up, one clear finding has emerged: veterans with high DU body burden show reduced bone mineral density, and this effect has worsened as the cohort has aged. The combination of ongoing uranium exposure and natural bone loss from aging appears to compound the problem.¹⁵ This is a small cohort with unusually high exposure, but the finding underscores that some consequences of Gulf War service are still unfolding.

What Is Happening in the Brain and Body

For years, GWI was sometimes dismissed as psychological, but brain imaging and biological research have moved firmly past that debate. A PET imaging study provided the first direct evidence of widespread neuroinflammation in the brains of veterans with GWI. Compared to healthy controls, veterans with the illness showed elevated markers of activated inflammatory cells across multiple brain regions, including areas involved in movement, sensation, and executive function.¹⁶ Structural MRI studies have also found significant shrinkage in deep brain structures including the brainstem, thalamus, and ventral diencephalon, without changes in the outer cortex.¹⁷

Beyond the brain, there is strong evidence that GWI involves damaged energy production at the cellular level. Mitochondria, the structures inside cells that generate energy, appear to function poorly in affected veterans. Using a specialized MRI technique that measures how quickly muscles recover their energy stores after exercise, researchers found that veterans with GWI took about 50% longer to replenish energy compared to healthy controls. That finding held up across two independent groups of participants.¹⁸ In a separate study, impaired mitochondrial function was a better predictor of how severe a veteran’s symptoms were than blood markers of inflammation, suggesting that energy failure may be more central to the illness than the body’s inflammatory response.¹⁹

The autonomic nervous system, which controls involuntary functions like heart rate, digestion, and sweating, is also disrupted. A population-based study confirmed that Gulf War veterans with chronic multi-symptom illness had significant autonomic dysfunction, including reduced sweat output in a pattern suggesting peripheral nerve damage, blunted heart rate variability at night, and elevated symptoms of digestive disruption and orthostatic intolerance.²⁰ Gastrointestinal autonomic symptoms were found to be the single most influential factor predicting physical functioning, accounting for a large share of the variation in how well affected veterans could perform daily activities.²¹

Long-term Neurological Risks

One of the more alarming findings in Gulf War veteran health research involves ALS, the progressive neurodegenerative disease. A review of the literature found that three out of six cohort studies looking at Gulf War deployment and ALS risk reported a significantly increased risk among those who were deployed.²² A large prospective study found that military service in general was associated with about a 50% higher ALS death rate compared to men who never served, and the elevated risk appeared across nearly all branches.²³ ALS is now treated as a presumptive service-connected condition for all veterans with 90 or more days of active service.

For other neurological diseases, the picture is less clear. A 13-year follow-up comparing Gulf War veterans to non-deployed veterans found no statistically significant difference in mortality from brain cancer, multiple sclerosis, or Parkinson’s disease.²⁴ That is somewhat reassuring but does not rule out non-fatal disease or conditions that develop later. Gulf War veterans are now in their 50s, 60s, and 70s, ages when neurodegenerative diseases become more common, and long-term surveillance remains important.

Treatments That Have Been Tested

There is no cure for Gulf War Illness, and the search for effective treatments has been frustrating. A systematic review of published randomized trials found that most interventions have shown either no benefit or only modest effects. A large, year-long trial of the antibiotic doxycycline found no benefit and more side effects than placebo. A short trial of rifaximin for IBS symptoms also found no effect.²⁵

Two approaches have shown some promise, though with caveats. Coenzyme Q10, a supplement involved in mitochondrial energy production, improved overall physical health and a range of individual symptoms at a dose of 100 mg daily in a small randomized trial. Interestingly, a higher dose of 300 mg did not perform as well. The improvement tracked with how much each veteran’s blood CoQ10 levels actually rose, which strengthens the case that the benefit was real rather than a placebo effect.²⁶ Cognitive behavioral therapy combined with exercise showed modest benefits on fatigue, cognitive functioning, and mental health that persisted up to a year after the intervention ended.

A more unconventional approach, a low-glutamate diet, showed preliminary evidence of lowering blood pressure in veterans with GWI in a small randomized trial.²⁷ These are early findings, and the field is still searching for treatments that address the root biological mechanisms rather than individual symptoms.

How Gulf War Illness Overlaps With and Differs From Other Conditions

GWI shares surface-level similarities with chronic fatigue syndrome (also called ME/CFS), and the two conditions are sometimes confused. A metabolic study comparing blood chemistry between the two found that while veterans with GWI and people with ME/CFS both showed abnormalities in many of the same biochemical pathways, four of the five shared pathways were regulated in opposite directions. In other words, pathways that were ramped up in GWI were dialed down in ME/CFS.²⁸ Lipid abnormalities, particularly elevated ceramides and certain phospholipid species, accounted for the majority of the metabolic disruption in GWI. This kind of biochemical fingerprinting matters because it suggests GWI is not simply another name for chronic fatigue; it has its own biology, which could eventually lead to targeted treatments.

The multinational scope of the illness also points away from a purely psychological explanation. Health registry evaluations of nearly 150,000 Gulf War veterans from the U.S., UK, Canada, and Australia revealed a consistent pattern of increased mental health diagnoses, multi-symptom conditions, and musculoskeletal disorders, but no single novel disease unique to Gulf War service.²⁹ The consistency across four countries with different military cultures and healthcare systems argues that the exposures themselves, rather than cultural factors or compensation-seeking behavior, are driving the illness. At the same time, no single Gulf War exposure has been pinpointed as the definitive cause, which is part of why the presumptive framework exists: the science supports a strong association with service even when it cannot isolate one culprit.

Emerging Diagnostic Tools

One of the persistent challenges with GWI is that it has no standard diagnostic blood test or imaging scan. Veterans are diagnosed based on symptom questionnaires and clinical case definitions, which is part of why prevalence estimates vary so widely. But several biological markers are moving closer to clinical usefulness.

The metabolic profiling approach mentioned above identified specific lipid signatures that distinguish GWI from both healthy controls and ME/CFS. Brain imaging using PET scans can now detect the neuroinflammation characteristic of the illness. And measures of mitochondrial function, whether through blood assays or the specialized MRI technique that measures muscle energy recovery, correlate with symptom severity in ways that could eventually help track treatment response. Blood levels of C-reactive protein, a common inflammatory marker, have been linked to white matter changes in the brain on imaging, though its role as a predictor of symptom severity has turned out to be more complicated than originally thought.³⁰ None of these tools are ready for routine clinical use yet, but they represent a shift from treating GWI as a diagnosis of exclusion toward identifying it with objective biological evidence.